Clinical Trial Update: Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating neuroma perfusion using indocyanine green fluorescence angiography has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroma
• Neuroma of Lower Limb
• Neuroma of Upper Limb

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Northwestern University | Conditions: Neuroma, Neuroma Amputation | Phase 4 | Status: WITHDRAWN